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Summary
Hydrogenated oils tend to have a higher trans fatty acid (TFA) content than oils that
do not contain hydrogenated fats. Prospective epidemiological and case-control studies
support a major role of TFAs in the risk of cardiovascular disease. In the partially hydro-
genated soybean oil, which is the major source of TFAs worldwide, the main isomer is
trans-10 C18:1. In the European countries with the highest TFA intake (the Netherlands
and Norway), consumption of partially hydrogenated fish oils was common until the mid-
-1990s, after which they were omitted from the dietary fat intake. These partially hydroge-
nated fish oils included a variety of very long-chain TFAs. Recent findings from Asian
countries (India and Iran) have indicated a very high intake of TFAs from partially hydro-
genated soybean oil (4 % of energy). Thus TFAs appear to be a particular problem in de-
veloping countries, where soybean oil is used. In 2003, the United States Food and Drug
Administration issued a final ruling that required food manufacturers to list the TFAs in
their foods on the nutritional facts label. One way to produce 'zero' levels of TFAs is the
trans-esterification reaction between vegetable oils and solid fatty acids, like C8:0, C12:0,
C14:0 and C16:0.
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Introduction
According to various studies, fats of animal and
vegetable origins satisfy 22 to 42 % of the daily energy
demands of human beings (1–3). Some fats, and espe-
cially those that are hydrogenated, contain trans fatty ac-
ids (TFAs), i.e. unsaturated fatty acids with at least one
double bond in a trans configuration (4). This trans dou-
ble-bond configuration results in a greater bond angle
than for the cis configuration, thus producing a more ex-
tended fatty acid carbon chain that is more similar to
that of the saturated fatty acids (SFAs), rather than to
that of the cis-unsaturated double-bond-containing fatty
acids (5,6).
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Formation of these double bonds thus impacts the
physical properties of a fatty acid. Fatty acids that con-
tain a trans double bond have the potential for closer
packing and alignment of their acyl chains, which re-
sults in decreased molecular mobility (2). Therefore, the
oil fluidity will be reduced when compared to that of
fatty acids that contain a cis double bond. Partial hydro-
genation of unsaturated oils results in the isomerisation
of some of the remaining double bonds and the migra-
tion of others, producing an increase in the TFA content
and hardening of the fat. It has been shown that foods
that contain hydrogenated oils tend to have a higher
TFA content than those that do not contain hydroge-
nated oils (4–6). Nevertheless, the hydrogenation of oils,
such as corn oil, can result in both cis and trans double
bonds, which are generally located anywhere between
carbon 4 and carbon 16 of the fatty acids.
Elaidic acid (trans-9 C18:1) is one of the major TFAs,
although during hydrogenation of polyunsaturated fatty
acids (PUFAs), small amounts of several other TFAs are
produced, including: trans-9,cis-12 C18:2; cis-9,trans-12
C18:2; cis-9,cis-12,trans-15 C18:3; and cis-5,cis-8,cis-11,
cis-14,trans-17 C20:5 (1,4,6).
Correlations between high intake of industrially pro-
duced TFAs (IP-TFAs) and the increased risk of coronary
heart disease (CHD) have been reported (7,8). Lowering
the intake of TFAs can also reduce the incidence of CHD
(2). Estimates based on changes in plasma concentra-
tions of low-density lipoprotein (LDL) and high-density
lipoprotein (HDL) indicate around 4 % reduction in
CHD incidence, while based on epidemiological associa-
tions, when TFA intake is lowered by 2 % (5 g/day), the
estimates indicate >20 % reduction (2,5,9). In the Nether-
lands, a major reduction in the TFA content of retail
foods was achieved in the 1990s, through the efforts of
the industry and with minimal government intervention
(9). Society pressure is also now helping to reduce the
TFA content of 'fast food'. This illustrates the feasibility
of reducing TFAs in fast food without increasing the sat-
urated fats, with the daily intake being kept as low as
possible to minimise health risks (7).
Prospective epidemiologic studies and case-control
studies using adipose tissue analyses have confirmed a
major role of TFAs in the risk of CHD. The magnitude
of the association with CHD is considerably stronger
than for SFAs, and it is stronger than that predicted for
the effects of TFAs on LDL and HDL cholesterol (2,5,
6,9). In this context, it needs to be considered that data
for the Russian Federation show that every year 1005
people per 100 000 of the population between 25 and 64
years of age die because of circulatory system diseases
(10). Consequently, in 2003, the United States Food and
Drug Administration issued a final ruling that required
food manufacturers to list the TFAs in the nutritional
facts labels of all packaged food products (11), with the
food industry being given until 1 January, 2006 to com-
ply. Along with these growing health concerns about
TFAs, this mandate has led to marked changes in the fat
and oil industries, with newer technologies developed
to reduce the TFA content of fats and oils used in the
manufacture of food products. Given the labelling man-
date and these technological advances, it is possible that
food products traditionally considered to be sources of
TFAs are now much lower in, or indeed do not contain,
TFAs (12). In late 2006, New York City became the first
major city in the United States of America to pass a reg-
ulation limiting IP-TFAs in restaurants. This has served
as a model for others to follow, with these regulations
including: a maximum level per serving size of 0.5 g of
TFAs; a distinction between frying and baking, with a
phased-in implementation; a help centre to assist restau-
rants in making the switch to more healthy options; and
plans to evaluate the regulation and its impact on CHD
(12).
Accurate quantification of C18:1 TFAs in food prod-
ucts is thus an important issue, with policies recently
implemented in different countries to limit their con-
sumption and their occurrence in food products because
of their relationship with CHD (11,13,14).
History
Margarine was invented in 1869 by Hippolyte Mège
Mouriès, a French food research chemist, in response to
a request by Napoleon III for a wholesome butter alter-
native. It is not entirely clear whether the primary aim
was the betterment of the working classes or the eco-
nomics of the food supply to the French army. In the
laboratory, Mège Mouriès solidified purified fat, after
which the resulting substance was pressed in a thin
cloth, which formed stearine and discharged oil. This oil
formed the basis of the butter substitute. For the new
product, Mège Mouriès used margaric acid, a fatty acid
component isolated in 1813 by the Frenchman Michel
Eugène Chevreuil. While analysing the fatty acids that
are the building blocks of fats, he singled out this one
and named it margaric acid because of the lustrous
pearly drops that reminded him of the Greek word for
pearls, i.e. margarites (4,14,15).
In 1871, Mège Mouriès sold this know-how to the
Dutch firm Jurgens, which is now part of Unilever. In
the early days, margarine contained two types of fat: a
large proportion of animal fat and a small proportion of
vegetable fat. As time passed, the small vegetable ele-
ment increased, through two specific stages in the pro-
cess. First, by improving the process of refining vegeta-
ble oils, the use could be made of a greater variety of
liquid oils and a higher proportion of solid vegetable
fats. Second, through the development of processes for
turning liquid oils into solid fats on a commercial scale,
the use could be made of larger quantities of liquid veg-
etable oils (15).
During the early years of that period, in the late
1800s, TFA intake from partially hydrogenated vegetable
oils was minimal. Indeed, it was not until the late 1800s
that the process of partial hydrogenation of oils was in-
vented in Europe. These partially hydrogenated oils ap-
parently entered the United States food supply by 1920.
Although the rate of increase before 1950 is not com-
pletely clear, by 1950 the amount of IP-TFAs in the food
supply was quite substantial. Partly because of econo-
mic effects during World War II, margarine production
rose rapidly as a replacement for butter (14,15). Then
during the 1960s, margarine became viewed as a healthy
alternative to butter because of its absence of cholesterol
and its low content of SFAs. Thus, consumption in-
creased further, and so margarine, which was heavily
hydrogenated at that time, became widespread in the
food supply and was the major source of IP-TFAs. This
phenomenon is illustrated in Fig. 1 (16). Total consump-
tion was approx. 2 to 3 % of the food energy. Since then,
the sources of TFAs have changed from mainly marga-
rine to mainly deep-fried fast foods and commercially
baked products, but per capita, the intake has remained
roughly the same (2,14,15).
After World War II, the process of making hydro-
genated and hardened fats from cheaper sources of vege-
table oils was widely adopted. Margarines were de-
veloped and marketed as alternatives to butter, and
vegetable shortening increasingly replaced animal fats
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in cooking (17). As early as 1975, a group of scientists
led by Leo Thomas, at what is now the University of
Glamorgan in South Wales, suspected that deaths from
CHD were connected with eating partially hydrogen-
ated fats. It is now generally accepted that TFAs are ac-
tually worse for health than the SFAs that they were de-
signed to replace (18).
Studies on Animals
In milk fat, TFAs are produced by anaerobic fermen-
tation of PUFAs in the rumen of lactating cows (19,20).
This fermentation process is called biohydrogenation,
and it results in TFAs that can be further metabolised in
the mammary gland. Accurate estimations of fatty acid
composition are vital not only for the definition of the
nutrient composition of food, but also to accurately de-
termine treatment effects that can alter the fatty acid
composition of the food (21–25).
There is a considerable overlapping of TFA isomers
in fats of ruminant origin and partially hydrogenated
vegetable oils, as they have many isomers in common.
However, there are considerable differences in the
amounts of individual TFAs in both sources. While there
is evidence of unfavourable effects of TFAs from hydro-
genated vegetable oils on LDL and other risk factors for
atherosclerosis, at present it is uncertain which of the
component(s) of the TFAs created by chemical hydroge-
nation are responsible for such a negative metabolic ef-
fect (21). Prospective studies addressing the effects of
TFA intake on CHD risk, where estimates of TFA intake
were based on dietary protocols, have mostly been car-
ried out in populations with a relatively low intake of
dairy or ruminant TFAs (26). Nevertheless, the biggest
effects of fatty acid composition and the nutritive qual-
ity of foods of animal origin, like meat and milk prod-
ucts, depend on the feed quality and the health of the
animals.
Studies on Humans
These TFA-containing fats can be incorporated into
both foetal and adult tissues, although the transfer rate
through the placenta continues to be a contradictory
subject. In preterm infants and healthy term babies, the
trans isomers have been inversely correlated with infant
birth mass. Maternal milk reflects precisely the daily di-
etary intake of TFAs, with 2 to 5 % of total TFAs in
human milk. The levels of linoleic acid in human milk
are increased by a high trans diet, although long-chain
polyunsaturated TFAs remain mostly unaffected (27–29).
Alterations in the maternal dietary intake of PUFAs
cause similar changes in the PUFA content of the milk.
Several investigations have shown that supplementation
of maternal milk with fish oils increases the amounts of
C20:5n-3 and C22:6n-3 in the milk and in maternal and
infant erythrocyte lipids. Likewise, infant tissues incor-
porate TFAs from maternal milk, increasing the levels of
linoleic acid and decreasing arachidonic and docosahex-
aenoic acids. This suggests an inhibitory effect of TFAs
on liver n-6 fatty acid desaturase activity (30,31). As op-
posed to blood and liver, the brain appears to be pro-
tected from TFA accumulation in experimental animals,
although no data have yet been reported for human
newborns (32). A significant interaction between diet
and pregnancy was detected in the activities of D6-de-
saturase and glucose-6-phosphatase in liver microsomes;
dietary TFAs decreased the activities of both enzymes,
although only in pregnant rats (33–35). In Spain TFAs in
human milk were investigated by Boatella et al. (36),
who showed that the average content of TFAs in 38
samples was 0.98 % of the fatty acids. This value was
lower than that for human milk from other developed
countries, where consumption of hydrogenated fat was
higher. In a study by Chen et al. (37) on TFAs in human
milk in Canada, the mean total TFA content was (7.19±
3.03) % of the total milk fatty acids, with a range from
0.10 to 17.15 %.
Compelling data linking dietary TFAs to increased
risk of CHD have originated from large, prospective,
population-based studies, which have included from 667
to 80 082 men and women across different age groups
who were monitored from 6 to 20 years; this link has
also been seen in controlled feeding trials (6). Among
these studies, there are the United States health profes-
sional's follow-up study, the Finnish a-tocopherol, b-car-
otene cancer prevention study, the United States nurse's
health study (with 14-year and 20-year follow-up) (2),
and the Dutch Zutphen elderly study (6). These studies
are consistent in the finding of a strong positive associa-
tion between TFA intake and the risk of CHD. Interest-
ingly, a weaker correlation between SFA intake and the
risk of CHD has also been reported (2).
The Zutphen elderly study studied 667 men from 64
to 84 years of age and free of CHD at baseline (6). Di-
etary surveys were used to establish the food consump-
tion patterns of the participants. Information on risk fac-
tors and diet were obtained in 1985, 1990 and 1995.
After a 10-year follow-up, from 1985–1995, there were 98
cases of fatal or non-fatal coronary heart disease. The
findings showed that in this period the mean TFA intake
decreased from 4.3 to 1.9 % of the food energy. After ad-
justment for age, body mass index, smoking and dietary
covariates, TFA intake at baseline was positively associ-
ated with the 10-year risk of CHD. Thus a high intake of
TFAs, which included all types of isomers, contributed
to the risk of CHD. A substantial decrease in TFA intake,
which was mainly due to the lowering of the TFA con-
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Fig. 1. Relative food energy supplied by the different fatty acids,
and the predicted changes for the food industry, including
breeding and fat hydrogenation (16)
tent in edible fats in the Dutch industry, would therefore
have a large impact on public health (4,6,32).
In multiple and rigorous randomised trials, the in-
take of TFAs has been consistently shown to have ad-
verse effects on blood lipids, and most notably on the
LDL/HDL cholesterol ratio, which is a strong marker of
cardiovascular risk. When a mixture of TFA isomers ob-
tained by partial hydrogenation of vegetable oils is used
to replace oleic acid, there is a dose-dependent increase
in the LDL/HDL ratio. The relationship between the
levels of TFAs as the percentage of energy and the in-
crease in the LDL/HDL ratio appears to be approximat-
ely linear, with no evidence of a threshold at low levels
of TFA intake, and with a slope that is twice as steep as
that observed by replacing oleic with an SFA (2,4,12,38).
Studies comparing animal and vegetable TFAs have
shown similar effects on the total/HDL cholesterol ratio.
Effects of TFA on lipoproteins from both sources ap-
peared at doses exceeding 2 % of energy (38). The aver-
age impact of TFA-induced changes in the LDL/HDL
ratio corresponds to tens of thousands of premature
deaths in the United States alone. Although dramatic,
this effect is substantially smaller than the increase in
cardiovascular mortality associated with TFA intake in
epidemiological studies, suggesting that other mecha-
nisms are likely to contribute to the toxicity of TFAs
(39).
Although there is accumulating evidence linking in-
flammatory proteins and other biomarkers to CHD,
lipid concentrations in the blood remain one of the
strongest and most consistent predictors of risk. There-
fore, the LDL/HDL cholesterol ratio is probably the best
marker to date for estimating the effects of TFAs on
plasma lipids, which are most likely relevant to CHD in-
cidence and mortality (32,39).
Further rigorous randomised trials to establish the
effects of hydrogenated fats and TFA intake on individ-
ual lipoprotein classes started in 1990, when a report
from the Netherlands suggested that a diet enriched with
elaidic acid (trans-9 C18:1) increased the total and LDL
cholesterol concentrations and decreased HDL choles-
terol concentrations, compared to a diet enriched with
oleic acid. In contrast, enrichment of the diet with SFAs
increased LDL cholesterol, but had no effect on HDL
cholesterol, thus resulting in a less adverse change than
in the case of elaidic acid (38,40).
Trans Fatty Acids and Legislation
Governments are increasingly recognizing that the
risks to consumers from the increased consumption of
TFAs cannot be ignored. In 2003, Denmark became the
first country to introduce laws to control the sale of
foods containing TFAs. In January 2006, it became law in
the United States of America that the contents of TFAs
have to be specifically listed on food labels. There is a
complication to this, however, because foods that con-
tain less than 0.5 g of TFA per serving can be labelled as
being free of TFAs. Furthermore, the regulations only
apply to food that is labelled; food sold in restaurants
and canteens is not covered by this law (5,7,11).
However, in December 2006, the Board of Health of
New York City banned many TFAs from restaurants in
the city, prompting similar moves in Philadelphia,
Montgomery County in Maryland, and the Boston sub-
urb of Brookline. The first phase of the regulation ap-
plies to oils, shortening and margarine used in cooking
and as spreads, for recipes that contain more than 0.5 g
of TFA per serving. Since 1 July 2007, New York City of-
ficials have also called for restaurants to clearly display
calorie counts next to their menu items in a bid to in-
crease consumer awareness of the nutritional content of
their food. By 1 July 2008, the ban had been extended to
include TFAs used in baked goods, including bread and
cakes, in prepared foods, salad dressings and oils used
for deep frying, and in dough and cake batter. Similar
bans are being proposed in Chicago and in the state of
Illinois; other cities may follow suit, most likely in Cali-
fornia (17,18).
The American Heart Association recommends a
healthy dietary pattern and lifestyle to combat heart dis-
ease, limiting TFA consumption to less than 1 % (or
approx. 2 g on a 2000-calorie diet) and saturated fat to
less than 7 % of total daily calories (12). This is consis-
tent with the TFA recommendations made by the Amer-
ican Dietetic Association and the Dietitians of Canada
(41).
The Danish story started with the publication of a
study in the Lancet by Willett in 1993, and ended when
IP-TFAs were reduced in the Danish market following a
ban in 2003 (2). The Danish Nutrition Council was es-
tablished in 1992, and it was the driving force behind
the campaign that convinced Danish politicians that IP-
-TFAs can be removed from foods without any effects
on taste, price or availability of foods. The Nutrition Coun-
cil argued that as no positive health effects of IP-TFAs
had ever been reported, then just the suspicion that a
high intake has harmful effects on health justified the
ban (42). The Danish success story might be interesting
for other countries where this unnecessary health haz-
ard could be eliminated from the foods.
Analytical Methods for Trans Fatty Acid
Determination
The fatty acid composition of food is usually deter-
mined by gas-liquid chromatography of the correspond-
ing methyl esters (43–50). Usually, fatty acid methyl es-
ters (FAMEs) can be conveniently prepared by heating
lipids with a large excess of either acid- or base-cata-
lysed reagents. Most of the analytical methods are time
consuming and impractical for processing large numbers
of samples, because lipids have to be extracted prior to
FAME preparation. For these reasons, some procedures
have been developed that can be used to prepare FAMEs
directly from fresh tissue (46,47).
Distribution of Trans Fatty Acids
Vaccenic acid (trans-11 C18:1) accounts for over 60 %
of the natural TFAs, whereas among IP-TFAs, a broad
mixture of TFAs is produced, with elaidic acid (trans-9
C18:1) as the main source (6). In recent years, newer
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technologies have been developed to reduce the TFA
content in fats and oils used in the manufacture of food
products. The content of TFAs in Danish food has been
monitored for the last 30 years. In margarine and short-
ening, the content of TFAs has steadily declined, from
about 10 g per 100 g of margarine in the 1970s, to practi-
cally no TFAs in margarine in 1999. To efficiently reduce
the health risk related to TFAs, Denmark decided to im-
pose a maximum level of IP-TFAs of 2 g per 100 g of fat,
as labelling was deemed insufficient to protect consum-
ers, and especially for risk groups like children and peo-
ple with a high intake of fast foods (3,51).
In North America, the daily TFA intake was esti-
mated using food frequency questionnaires, and it was
found to be 3–4 g per person, and by extrapolation of
human milk data, to be greater than 10 g per person.
The data show that the levels of TFAs can vary consider-
ably among foods within any specific category, reflecting
the differences in the fats and oils used in the manufac-
turing or preparation processes. For example, the range
of TFAs in 17 brands of crackers was 23 to 51 % of total
fatty acids, which represents differences of 1 to 13 g of
TFAs per 100 g of crackers. This study shows that the
wide variability in the TFA content of different foods can
result in large errors in the estimation of TFA intake of
individuals and, potentially, of groups (52).
TFA consumption in European countries varies con-
siderably. The diet in northern European countries tradi-
tionally contains more TFAs than that in the Mediterra-
nean countries, where olive oil is commonly used. The
diet in France has always been relatively low in TFAs
because France has traditionally used predominantly ru-
minant fats, as compared to hydrogenated vegetable
oils. Recent decrease in dietary TFAs has been seen due
to the modification of commercial fats and changes in
consumer choice (2,4,32). In the TRANSFAIR study (53),
which was based on a market basket analysis of diets in
14 European countries, the mean daily intake of TFAs
ranged from minimal intake in Greece (1.4 g of TFA per
day) to the highest intake in Iceland (5.4 g of TFA per
day) (Fig. 2, 2–4,51,53).
Milk fat is also the most abundant source of conju-
gated linoleic acids (CLAs), which refers to a group of
geometrical and positional isomers of linoleic acid (LA
cis-9,cis-12 C18:2). The major isomer of the CLAs in milk
fat is cis-9, trans-11, and it represents 80 to 90 g per 100 g
of total CLAs (54–56). Some of these fatty acids have bio-
logical, physiological and nutritional properties that are
very interesting for consumer health, as especially seen
for butyric acid and CLAs (17,26,57). CLAs are synthe-
sised in ruminants both from dietary linoleic acid (cis-9,
cis-12 C18:2) in the rumen by the microbial flora, and
from vaccenic acid (trans-11 C18:1) in the mammary
glands during de novo synthesis (58).
About half of the convenience products on the Aus-
trian market that were tested contained less than 1 % of
TFAs, and one third less than 5 % (3). However, almost
5 % of the products tested contained more than 20 %
TFAs. A similar level was seen for fast food products,
with the highest TFA levels of 8.9 %. Total TFAs of house-
hold fats were lower ((1.45±1.99) %) than fats for indus-
trial use ((7.83±10.0) %; p<0.001). Compared to the in-
vestigations in Austria and Germany, around 10 years
ago the TFA content of the tested foods decreased signifi-
cantly. About half of the investigated products contained
less than 1 % of TFAs or total fatty acids, although very
high levels of TFAs (>15 %) are still detected, and an in-
take of more than 5 g of TFA per portion is possible,
which has been shown to significantly increase the risk
of CHD (2,3,6).
Brát and Pokorný (59) investigated a series of 20 mar-
garines, nine cooking fats, and butter that were available
on the Czech market. They used the American Oil Chem-
istry Society (AOCS) standard analysis methods, apply-
ing capillary gas chromatography. The margarines con-
tained 15.2 to 54.1 % cooking fats, and 16.5 to 59.1 %
SFAs, which was less than the butter. The content of li-
noleic acid varied between 3.7 and 52.4 % in the marga-
rines, small amounts of linolenic acid were present in
most samples, while oleic acid prevailed in cooking fats.
Monoenoic TFAs were present only in trace amounts in
10 samples, and trans-polyenoic acids were present only
in small amounts. Most cooking fats had a high content
of TFAs. They summarised these data by indicating that
the number of trans-free margarines had rapidly in-
creased over a few years.
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Fig. 2. Daily intake of TFAs in European countries (2–4,51,53)
More recently, Cen~i~-Kodba (60) examined 13 mar-
garines and fatty food samples in Slovenia, which were
selected according to the frequency of use within differ-
ent population groups in the community. All of the fried
food and bakery food samples included in this study
contained TFAs. The levels varied from less than 0.5 to
6.8 %. The highest TFA content in the margarines was
5.2 %, with 0.3 % as the lowest, and a mean TFA content
of 2.3 %. The main TFAs were the trans isomers of mo-
nounsaturated octadecenoic acid (C18:1).
The findings of Larqué et al. (61) suggest that Span-
ish margarines have moved to becoming products with
a potentially healthier distribution of fatty acids. Even
so, the great variability shown in fatty acid composition
of margarines and the poor labelling highlight the im-
portance of greater consumer information to avoid up-
setting the traditional Mediterranean diet in Spain.
Conclusions and Future Trends
It can be concluded at present that the reduction of
TFAs in the food supply is a complex issue that has in-
volved interdependent and interrelated stakeholders.
Actions to reduce TFAs need to be carefully considered
regarding both the intended and unintended consequen-
ces related to nutrition and public health. World Health
Organization (62) has already included the amount of
TFAs in daily intake recommendations (Table 1). Many
different options of alternative oils and fats that can be
used to replace TFAs are available or are being devel-
oped. However, decisions on which alternatives to use
are complicated and often time-consuming, and they in-
volve considerations of health effects, availability, re-
search and development investments, food quality and
taste, supply chain management, operational modifica-
tions, consumer acceptance, and cost (11,12).
As industry responses are now well underway fol-
lowing the policy actions of the past few years, it is pos-
sible to take a snapshot of industry activities that pro-
vides preliminary answers to these considerations. The
first results of most anti-trans fat campaigns can be seen
as modifications of the fatty acid compositions of indus-
trial fats. In those fats, there are significantly higher lev-
els of SFAs and possibly a higher index of atherogeni-
city. Several major food companies have announced
efforts to remove TFAs from their leading brands over
the past decade, starting with Unilever in the 1990s, and
then more recently with Nestlé in 2002, Kraft in 2003,
Campbell's in 2004 (for Goldfish crackers), Kellogg's in
2005, and Frito-Lay in 2006 (for chips). It is of note that
the earliest announcements came from European firms,
where the use of partially hydrogenated soy was not as
common as in the United States, and thus reformulation
was not as onerous. The announcements over the last
three years have reflected the attention brought to this
issue through lawsuits and debates about the nutritional
label regulations. Many companies chose to implement
the disclosure of these trans fat contents earlier than Jan-
uary 1, 2006 deadline, particularly when they were able
to advertise zero trans fats on their products (63).
One aspect for producing 'zero' TFA fats lies in the
transesterification reactions between vegetable oils and
the SFAs of C8:0, C12:0, C14:0 and C16:0. These reac-
tions are catalysed by an immobilised sn-1,3 specific
Rhizomucor miehei lipase. One aspect relating to a TFA-
-free or low TFA fat that is suitable for use in confection-
ery fats is a non-hydrogenated vegetable fat composed
of an inter-esterified fat: this can be obtained by subject-
ing a blend of at least one fat rich in lauric acid and at
least one fat without lauric acid to inter-esterification
(64).
For all of the products introduced in 2005 and 2006
that claimed to contain 'no trans fats', the most com-
monly used oil ingredients were canola, sunflower and
soybean oils. Palm oil, which is high in saturated fat,
also appears among commonly used ingredients, but is
not as commonly used as an alternative in reducing
TFAs. Some products (11 %) still use partially hydroge-
nated oils, because the regulation allows 0.5 g per serv-
ing of trans fats in products that can claim to contain 'no
trans fat', while the use of small amounts of partially hy-
drogenated oils has facilitated the reformulation of some
products (65).
Between 2006 and 2007, consumer awareness of
trans fats increased and attained levels similar to those
for saturated fats. This increased awareness is associated
with improved self-reporting behaviour in consumer
shopping for groceries (66). However, food labels and
food claims that accompany packed foods are still largely
incomprehensible for consumers and therefore they re-
main almost useless. Moreover, in Europe, consumers
still cannot identify the content of TFAs in the labelling
of food products, particularly as the only legislation that
restricts the content of TFAs in Europe is in Denmark.
At the same time, we have to be aware that some
indicators are showing that the world population is still
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Saturated fatty acids <10
Polyunsaturated fatty acids 6–10
n-6 polyunsaturated fatty acids 5–8
n-3 polyunsaturated fatty acids 1–2





Sodium chloride (sodium) <5 g/day (<2 g/day)
Fruits and vegetables >400 g/day
Total dietary fibre from foods>25 g/day
aexcept where specified otherwise
bas 'total fat (saturated fatty acids+polyunsaturated fatty
acids+trans fatty acids)'
cpercentage of total energy available after taking into account
what is consumed as protein and fat, hence the wide range
d'free sugars' refers to all monosaccharides and disaccharides
added to foods by manufacturers, cooks or consumers, plus
sugars naturally present in honey syrups and fruit juices
increasing and is expected to reach nearly 8.9 thousand
million (8 900 000 000) by the year 2050 (67). In the fu-
ture, it will become increasingly difficult to assure food
security as well as food safety, and also the nutritional
quality of food. Indeed, it is the nutritional quality of
food and its distribution all over the world that are the
main factors which will have a huge impact on human
health. In this way, human health is more than just of
personal value, as it is also part of the welfare of the
whole of our society.
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